The dosage market size value per capita for Penicillins and Streptomycins in Estonia has shown a steady decline from 2013 to 2023, dropping from $5.3 to $1.55. The year-on-year change from 2022 to 2023 reflects a 19.7% decrease. Over the past five years (from 2018 to 2023), the compound annual growth rate (CAGR) indicates an average yearly decline of approximately 12.9%.
Future Trends to Watch For:
- Shifts toward alternative antibiotics due to increased resistance.
- The influence of healthcare policy changes on prescription practices.
- Continued scrutiny on antibiotic usage and potential impacts on market size.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 26 | 26 Armenia | 1.75 | 2023 | View data | ||
| 27 | 27 Kyrgyzstan | 1.57 | 2023 | View data | ||
| 28 | 28 Estonia | 1.55 | 2023 | |||
| 29 | 29 Thailand | 1.27 | 2023 | View data | ||
| 30 | 30 Ghana | 0.63 | 2023 | View data | ||
